Drugs of Abuse Flashcards
Drugs that activate G protein coupled receptors
- opioids
- cannabinoids
- hydroxybutyric acid (GHB)
- LSD, mescaline, psilocybin
main receptor target of opioids
OR (Gio)
Agonist
Drugs that bind to Inotropic Receptors and ion channels
- nicotine
- alcohol
- benzodiazepines
- phencyclidine, ketamine
drugs that bind to transporters of biogenic amines
- ampheatmines
* ecstacy
Symptoms of opioid withdrawal
➢ Intense dysphoria, nausea vomiting, muscle aches, Lacrimation, rhinorrhea
➢ Yawning and sweating
➢ Chills, goose flesh (“cold turkey”)
➢ Tremors, muscle jerks (“kicking the habit”)
treatment of opioid withdrawal
➢ Treatment of withdrawal: substituting with Methadone or buprenorphine…followed by its slow dose reduction
➢ Clonidine is also found to be effective for withdrawal
➢ Use of opioid antagonist (naloxone, naltrexone) in an abuser may precipitate withdrawal (precipitated withdrawal)
CNS effects of Cannabinoids
- A feeling of being “High”
- euphoria
- uncontrollable laughter
- increased appetite
- altered sense of time
- difficulty concentrating
- decreased memory
- Vasodilation and tachycardia
- Habitual users show Reddened conjunctiva
cannabinoids MOA
• THC is an agonist at CB1 & CB2 (cannabinoid) receptors
• CB receptors are in many areas of the CNS
➢ Therapeutic Used THC analog is Dronabinol
➢ used to treat –
• Nausea & vomiting in patients receiving cancer chemotherapy
➢ Rimonabant CB1 receptor agonist
➢ FDA approved use to treat obesity, smoking cessation (offlabel use)
Rimonabant
CB1 receptor agonist
g-HydroxyButyrate (GHB)
➢ Site of action: weak agonist on GABAB receptor
➢ Lactone (GBL) may be found in nail polish remover
➢ Effects – used as hypnotic:
• Euphoria
• Enhanced sensory perception
• Feeling of social closeness
• Amnesia, general anesthesia, coma, death
➢ Pharmaceutical properties: rapid onset, short half-life
• –tmax = 20-30 min; t1/2 = 60 min
• Odorless liquid
➢ “Club drug” “date rape drug”
psilocybin
hallucinogen
Dronabinol
Therapeutic Used THC analog
used to treat –
• Nausea & vomiting in patients receiving cancer chemotherapy
mescalin
hallucinogen
Rimonabant
CB1 receptor agonist
LSD has activity at
agonist activity at 5-HT2A receptors